Lactalis has released a statement announcing Philippe Palazzi’s departure from his role as CEO of the company after just over a year, effective 3 February.
In the statement, Emmanuel Besnier, the company’s president and primary shareholder, thanked Palazzi “for his investment and his energy which made it possible to achieve the financial objectives for the year 2021”.
Palazzi was appointed CEO of Lactalis commencing 1 January 2021. He said that he wishes “Emmanuel Besnier and the Lactalis teams every success in pursuing the profitable and responsible growth that will ensure the future of this French family company”.
By Lauren Ford
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.